ELAVL1 and myeloid sarcoma: Indeed, the western blotting analysis revealed a significantly lower protein content of HuR (median 548; IQ: 480–686 vs. median 842; IQ: 691–1091, p < 0.001), MnSOD (median 300; IQ: 283–587 vs. median 599; IQ: 576–775, p < 0.01), and HSP70 (median 669; IQ: 513–911 vs. median 915; IQ: 734–1110, p < 0.05) in MS patients compared to HC (Figure 3A–C).